CryoLife Inc (CRY) Financials

$17.47

$-5.87 (-25.15%)

As on 04-Sep-2026 16:15EDT

Market cap

$703 Mln

Revenue (TTM)

$305 Mln

P/E Ratio

425.7

P/B Ratio

2.2

Div. Yield

0.2 %

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Operating Revenue	304.96	298.84	253.23	276.22	262.84	189.70
Cost of Revenue	104.57	101.32	85.44	93.21	89.86	61.06
Gross Profit	200.40	197.51	167.78	183.01	172.98	128.64
Operating Expenses	208.01	205.32	165.34	165.97	163.67	120.67
Operating Profit (EBIT)	-7.62	-7.81	2.44	17.04	9.31	7.97
Other Income	-4.27	-6.06	-2.92	-0.51	0.09	0.47
Profit before Tax	-12.76	-14.83	-17.17	1.64	-6.39	3.56
Provision for Tax	2.33	0.01	-0.49	-0.08	-3.55	-0.14
Profit after Tax (Net Income)	-15.09	-14.83	-16.68	1.72	-2.84	3.70
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-15.07	-14.83	-16.68	1.72	-2.84	3.70

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Shareholder's Funds	297.49	300.73	328.71	285.70	275.07	277.06
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	441.53	447.37	400.22	274.76	261.50	269.70
Current Liabilities	42.84	44.95	60.47	45.20	34.52	42.94
Total Liabilities	856.83	793.05	789.40	605.65	571.09	589.69

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Non-Current Assets	3.49	545.36	554.82	418.26	391.92	410.41
Current Assets	244.53	247.70	234.59	187.39	179.17	179.28
Total Assets	1,026.39	793.05	789.40	605.65	571.09	589.69
Total Debt*	--	362.04	298.04	221.82	223.55	226.39
Net Current Assets	--	202.74	174.12	142.20	144.65	136.34

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Cash From Operating Activities	--	-2.59	12.37	15.83	9.88	10.80
Cash Flow from Investing Activities	--	5.66	-73.13	-23.94	-6.72	-170.99
Cash from Financing Activities	--	-12.22	93.61	-1.49	-2.56	143.25
Net Cash Inflow / Outflow	--	-9.15	32.85	-9.61	0.60	-16.67

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
ROCE (%)	--	-2.30	-2.94	0.34	-0.57	0.94
ROE (%)	-4.95	-4.71	-5.43	0.61	-1.03	1.52
ROA (%)	-1.61	-1.87	-2.39	0.29	-0.49	0.82
EBIT Margin (%)	1.32	0.69	-0.19	5.98	3.58	4.45
Net Margin (%)	-5.02	-5.07	-6.66	0.62	-1.08	1.95
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Revenue Growth (%)	18.26	0.18	-0.08	0.05	0.39	0.05
EBIT Growth (%)	6.04	532.77	-102.88	75.91	11.31	-60.65
Net Profit Growth (%)	-14.67	11.08	-1,069.88	160.56	-176.67	-65.63
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Price / Earnings	425.71	--	--	--	--	--
Price / Book Value	2.22	--	--	--	--	--
Dividend Yield (%)	0.17	--	--	--	--	--
EV/EBITDA	22.53	11.79	11.69	5.40	6.62	10.21
Close Price ($)	20.25	20.35	23.61	27.09	28.38	19.15
High Price ($)	32.34	32.34	31.77	33.00	36.05	24.00
Low Price ($)	16.56	16.95	12.63	20.76	16.80	14.03
Market Cap ($ Cr)	703.21	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Debt to Equity	1.03	1.20	0.91	0.78	0.81	0.82
Short term debt to equity ratio	0.01	0.02	0.02	0.03	0.01	0.00
Current Ratio	5.71	5.51	3.88	4.15	5.19	4.18
Quick Ratio	3.93	3.80	2.67	2.97	3.87	3.09
Interest Coverage	0.24	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
Debtors to sales (%)	19.54	19.44	19.25	20.22	19.57	27.12
Asset Turnover	0.32	0.38	0.36	0.47	0.45	0.42
Receivable days	--	65.30	75.45	70.94	71.48	78.50
Inventory Days	--	270.38	269.54	193.09	187.31	218.27
Payable days	--	36.08	41.51	33.98	35.19	102.25
Cash Conversion Cycle	--	299.60	303.48	230.04	223.60	194.52

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)